Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Immunology (14:) - Lausanne : Frontiers - Art.-Id. 1056525
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Technische Universität Berlin
- (wann)
-
2023
- Urheber
-
Henze, Larissa
Braun, Julian
Meyer-Arndt, Lil
Jürchott, Karsten
Schlotz, Maike
Michel, Janine
Grossegesse, Marica
Mangold, Maike
Dingeldey, Manuela
Kruse, Beate
Holenya, Pavlo
Mages, Norbert
Reimer, Ulf
Eckey, Maren
Schnatbaum, Karsten
Wenschuh, Holger
Timmermann, Bernd
Klein, Florian
Nitsche, Andreas
Giesecke-Thiel, Claudia
Loyal, Lucie
Thiel, Andreas
- DOI
-
10.14279/depositonce-17133
- Handle
-
11303/18325
- URN
-
urn:nbn:de:101:1-2023032200591740881013
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Henze, Larissa
- Braun, Julian
- Meyer-Arndt, Lil
- Jürchott, Karsten
- Schlotz, Maike
- Michel, Janine
- Grossegesse, Marica
- Mangold, Maike
- Dingeldey, Manuela
- Kruse, Beate
- Holenya, Pavlo
- Mages, Norbert
- Reimer, Ulf
- Eckey, Maren
- Schnatbaum, Karsten
- Wenschuh, Holger
- Timmermann, Bernd
- Klein, Florian
- Nitsche, Andreas
- Giesecke-Thiel, Claudia
- Loyal, Lucie
- Thiel, Andreas
- Technische Universität Berlin
Entstanden
- 2023
Ähnliche Objekte (12)
The role of pre-existing cross-reactive central memory CD4 T-cells in vaccination with previously unseen Influenza strains
The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Plasmonic Cross‐Reactive Sensing Noses and Tongues
A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development
Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
The role of pre-existing cross-reactive central memory CD4 T-cells in vaccination with previously unseen Influenza strains
The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Plasmonic Cross‐Reactive Sensing Noses and Tongues
A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development
Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
The role of pre-existing cross-reactive central memory CD4 T-cells in vaccination with previously unseen Influenza strains
The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Plasmonic Cross‐Reactive Sensing Noses and Tongues
A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development
Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika